CN100340287C - 防止uvb引起的皮肤损伤的方法 - Google Patents

防止uvb引起的皮肤损伤的方法 Download PDF

Info

Publication number
CN100340287C
CN100340287C CNB028112849A CN02811284A CN100340287C CN 100340287 C CN100340287 C CN 100340287C CN B028112849 A CNB028112849 A CN B028112849A CN 02811284 A CN02811284 A CN 02811284A CN 100340287 C CN100340287 C CN 100340287C
Authority
CN
China
Prior art keywords
tsp
cells
uvb
skin
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB028112849A
Other languages
English (en)
Chinese (zh)
Other versions
CN1512868A (zh
Inventor
迈克尔·J·德特马
矢野喜一郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of CN1512868A publication Critical patent/CN1512868A/zh
Application granted granted Critical
Publication of CN100340287C publication Critical patent/CN100340287C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB028112849A 2001-04-13 2002-04-11 防止uvb引起的皮肤损伤的方法 Expired - Lifetime CN100340287C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28387401P 2001-04-13 2001-04-13
US60/283,874 2001-04-13

Publications (2)

Publication Number Publication Date
CN1512868A CN1512868A (zh) 2004-07-14
CN100340287C true CN100340287C (zh) 2007-10-03

Family

ID=23087934

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028112849A Expired - Lifetime CN100340287C (zh) 2001-04-13 2002-04-11 防止uvb引起的皮肤损伤的方法

Country Status (8)

Country Link
US (1) US6712617B2 (OSRAM)
EP (1) EP1377253A4 (OSRAM)
JP (1) JP2004526758A (OSRAM)
KR (2) KR20080108366A (OSRAM)
CN (1) CN100340287C (OSRAM)
CA (1) CA2446093A1 (OSRAM)
TW (1) TWI233361B (OSRAM)
WO (1) WO2002083088A1 (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266706A1 (en) * 2002-11-05 2004-12-30 Muthiah Manoharan Cross-linked oligomeric compounds and their use in gene modulation
TWI312681B (en) * 2001-02-01 2009-08-01 Novel physiologically active substance
TWI334866B (en) * 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
US7238370B2 (en) * 2002-06-14 2007-07-03 Rosenberg E William Method and composition to prevent and treat photoaging of skin
JP5122060B2 (ja) * 2002-06-25 2013-01-16 株式会社 資生堂 抗老化剤
EP1541570A4 (en) * 2002-07-31 2008-05-21 Mercian Corp NEW PHYSIOLOGICALLY EFFECTIVE SUBSTANCE
WO2004011661A1 (ja) * 2002-07-31 2004-02-05 Mercian Corporation 新規生理活性物質
AU2003282683A1 (en) 2002-10-04 2004-05-04 Photokinetix Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
DE10254214A1 (de) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz
NZ540103A (en) * 2002-11-29 2007-05-31 Mercian Corp Process for producing macrolide compound
AU2006246425B2 (en) * 2003-11-06 2012-03-22 Genencor International, Inc. Personal care compositions and methods for their use
WO2005097187A2 (en) * 2004-04-01 2005-10-20 The General Hospital Corporation Methods of preventing uvb-induced skin damage
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
WO2006042114A1 (en) * 2004-10-06 2006-04-20 Cook, Inc. Emboli capturing device having a coil and method for capturing emboli
US7831890B2 (en) 2004-10-12 2010-11-09 Aware, Inc. Resource sharing in a telecommunications environment
EP2561883A3 (en) * 2005-09-16 2013-04-17 Shiseido Company, Ltd. Novel vascular endothelial growth factor expression inhibitors
ATE476986T1 (de) 2006-01-18 2010-08-15 Gen Hospital Corp Verfahren zur steigerung der lymphatischen funktion
US8335956B2 (en) 2006-04-12 2012-12-18 Tq Delta, Llc Packet retransmission and memory sharing
WO2008005533A2 (en) * 2006-07-06 2008-01-10 Aaron Thomas Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
AU2007285215A1 (en) * 2006-08-14 2008-02-21 Eisai R & D Management Co., Ltd. Stable lyophilized preparation
MX2009008068A (es) * 2007-01-29 2009-11-18 Eisai R&D Man Co Ltd Compuesto macrolido en forma solida, proceso para su preparacion y composicion farmaceutica que lo contiene.
KR20100065190A (ko) 2007-09-14 2010-06-15 닛토덴코 가부시키가이샤 약물 담체
US9132202B2 (en) 2009-07-17 2015-09-15 Aaron T. Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
ES2687780T3 (es) 2009-09-30 2018-10-29 Shiseido Company, Ltd. Inhibidor de la actividad heparanasa
US12358963B2 (en) 2019-12-24 2025-07-15 Juvena Therapeutics, Inc. Regenerative polypeptides and uses thereof
WO2021133858A1 (en) * 2019-12-24 2021-07-01 Juvena Therapeutics, Inc. Heparin-associated polypeptides and uses thereof
CA3223707A1 (en) 2021-06-21 2022-12-29 Hanadie Yousef Regenerative polypeptides and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1258198A (zh) * 1997-05-27 2000-06-28 塞姆柏奥希斯遗传学公司 油体的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US6372234B1 (en) 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
WO1999026649A1 (en) * 1997-11-25 1999-06-03 Cornell Research Foundation, Inc. Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity
AU766098B2 (en) 1999-03-31 2003-10-09 General Hospital Corporation, The Thrombospondin-2 and uses thereof
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1258198A (zh) * 1997-05-27 2000-06-28 塞姆柏奥希斯遗传学公司 油体的用途

Also Published As

Publication number Publication date
US20030008821A1 (en) 2003-01-09
KR20040021598A (ko) 2004-03-10
KR20080108366A (ko) 2008-12-12
JP2004526758A (ja) 2004-09-02
CN1512868A (zh) 2004-07-14
EP1377253A4 (en) 2008-09-03
EP1377253A1 (en) 2004-01-07
WO2002083088A1 (en) 2002-10-24
US6712617B2 (en) 2004-03-30
TWI233361B (en) 2005-06-01
CA2446093A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
CN1512868A (zh) 防止uvb引起的皮肤损伤的方法
JP5960749B2 (ja) 毛の成長を調節する方法
US7175844B2 (en) Methods of modulating fibrosis
US6773881B2 (en) Methods of modulating hair growth
Haze et al. Regeneration of bone and periodontal ligament induced by recombinant amelogenin after periodontitis
US20080311083A1 (en) Methods of Modulating Beta Cell Function
CN101277672A (zh) 用于减少皮肤损伤的方法和组合物
CN1622797A (zh) 利用肌动蛋白结合肽促进毛发生长的方法和组合物
KR20070046064A (ko) 피부 손상 방지
US20020048581A1 (en) Modulation of nitric oxide synthase by PKC
JP2003505471A (ja) Ｖｇｆポリペプチドおよびｖｇｆ関連障害の治療方法
US20020048582A1 (en) Methods of modulating angiogenesis
AU2002254588B2 (en) Methods of Preventing UVB-Induced Skin Damage
WO2003083057A2 (en) Adipocytes and uses thereof
AU2002254588A1 (en) Methods of Preventing UVB-Induced Skin Damage
US6759201B2 (en) Method of identifying a neural progenitor cell by evaluating expression of daedalos
Xinyu et al. Exosome-Mediated Immunomodulation in Hair Regeneration: From Bench to Bedside
US20050136039A1 (en) Adipocytes and uses thereof
Hofmann et al. Anatomy and Embryology of the Thymus
HK1038886A1 (en) USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TREATMENT OF KIDNEY DISORDER
TW200418979A (en) Physiologically active polypeptide and its antibody and use thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20071003